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ABSTRACT
Objectives Moderate alcohol consumption is protective 
against rheumatoid arthritis (RA) development and 
associated with lower levels of systemic inflammation 
in RA and in the general population. We therefore 
hypothesised that moderate alcohol consumption is 
associated with less severe local inflammation in joints 
in RA, detected by MRI. Since asymptomatic persons 
can have low-grade MRI-detected inflammation, we also 
hypothesised that alcohol consumption is associated 
with the extent of MRI inflammation in asymptomatic 
volunteers.
Methods 188 newly presenting patients with RA and 192 
asymptomatic volunteers underwent a unilateral contrast-
enhanced 1.5T MRI of metacarpophalangeal, wrist and 
metatarsophalangeal joints. The MRIs were scored on 
synovitis, bone marrow oedema and tenosynovitis; the 
sum of these yielded the MRI inflammation score. MRI data 
were evaluated in relation to current alcohol consumption, 
categorised as non-drinkers, consuming 1–7 drinks/week, 
8–14 drinks/week and >14 drinks/week. Association 
between C reactive protein (CRP) level and alcohol was 
studied in 1070 newly presenting patients with RA.
Results Alcohol consumption was not associated with 
the severity of MRI-detected inflammation in hand and 
foot joints of patients with RA (P=0.55) and asymptomatic 
volunteers (P=0.33). A J-shaped curve was observed in the 
association between alcohol consumption and CRP level, 
with the lowest levels in patients consuming 1–7 drinks/
week (P=0.037).
Conclusion Despite the fact that moderate alcohol 
consumption has been shown protective against RA, 
and our data confirm a J-shaped association of alcohol 
consumption with CRP levels in RA, alcohol was not 
associated with the severity of joint inflammation. 
The present data suggest that the pathophysiological 
mechanism underlying the effect of alcohol consists of a 
systemic effect that might not involve the joints.
IntROduCtIOn
In the general population moderate alcohol 
consumption has been associated with lower 
levels of systemic inflammation, as several 
studies have shown that alcohol consumption 
is associated with levels of C reactive protein 
(CRP) in a J-shaped or U-shaped manner.1 2 
Individuals with an alcohol consumption of 
one to two drinks daily had the lowest CRP 
levels.
In rheumatoid arthritis (RA), the influ-
ence of alcohol consumption on the risk of 
developing RA has been studied extensively. 
Moderate alcohol consumption has been 
associated with a decreased risk of developing 
RA.3–5 The risk of developing RA was lowest 
in persons who consumed approximately 1 
unit of alcohol per day.3 In patients with RA, 
alcohol consumption was associated with 
lower levels of inflammatory markers (eg, CRP 
and erythrocyte sedimentation rate, soluble 
tumour necrosis factor receptor II, inter-
leukin-6 (IL-6)).6–8 For IL-6 levels a U-shaped 
association was also observed, with the lowest 
IL-6 levels in patients with RA who consumed 
1 unit of alcohol per day.6
Within RA the effect of alcohol on local 
inflammation in joints has been studied 
once using the swollen joint count (SJC), 
and no evident association between alcohol 
consumption and the number of swollen 
joints was observed in 1238 patients with RA.9 
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Key messages
What is already known about this subject?
 ► A J-shaped association between alcohol and C 
reactive protein was confirmed in the present study.
What does this study add?
 ► Alcohol was not associated with the extent of local 
inflammation in joints.
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Because MRI is more sensitive than the SJC in detecting 
local inflammation,10 we anticipated that MRI is useful 
in detecting an effect of alcohol on the severity of local 
inflammation in RA.
Furthermore, as the effect of alcohol on markers of 
systemic inflammation is also present in the general 
population,1 and since some asymptomatic persons of 
the general population also have low-graded MRI-de-
tected inflammation,11 12 an association between alcohol 
and joint inflammation might not be confined to patients 
with RA, but even be present in asymptomatic volunteers.
Therefore, we hypothesised that moderate alcohol 
consumption is associated with less inflammation in hand 
and foot joints, visualised by MRI, both in patients with 
RA and in asymptomatic volunteers. The present study 
evaluated these two hypotheses. Furthermore, to vali-
date the previously observed association between alcohol 
consumption and CRP level in RA, we also studied this 
association in our cohort of patients with RA.
MethOds
Participants
The patients with RA studied were consecutively included 
in the Leiden Early Arthritis Clinic (EAC). This is an 
inception cohort that includes patients with ≥1 swollen 
joint and a symptom duration of <2 years. When patients 
presented to the outpatient clinic, questionnaires were 
obtained that included a self-reported average number of 
alcohol consumptions per week (current consumption); 
information on the type of alcohol was not available. 
Furthermore, physical examination (among which 66 
SJC) was performed and blood samples were obtained.13 
RA was defined as fulfilling the 1987 American College of 
Rheumatology criteria during the first year of follow-up. 
From 1993 to 2016, 1244 patients with RA were included 
in the EAC cohort. The association between alcohol 
consumption and CRP was assessed in all patients with 
RA of whom alcohol consumption was available (1070 
patients with RA). From 2010 onwards MRI was added 
to the study protocol,10 and the association between 
alcohol and MRI-detected inflammation was assessed 
in 188 consecutive patients with RA who underwent an 
MRI at baseline (see  online supplementary figure 1 for 
a flow chart).
The asymptomatic volunteers were recruited between 
November 2013 and December 2014, and have been 
described earlier.12 Volunteers were recruited via adver-
tisements on local newspapers and websites. Volunteers 
had no history of RA or other inflammatory rheumatic 
diseases, no joint symptoms during the last month and 
no clinically detectable arthritis at physical examination. 
Questionnaires were obtained, including self-reported 
alcohol consumption. CRP levels were not assessed in 
these volunteers. One hundred and ninety-three volun-
teers underwent an MRI; in one of these persons, no 
data on alcohol consumption were obtained. The volun-
teers received a voucher of €20 to compensate for their 
time and travel costs and did not receive a report of the 
MRI. Therefore, volunteers had no/limited benefit from 
participating.
 All participants have given a written informed consent.
MRI protocol and scoring
A contrast-enhanced MRI was performed of the unilat-
eral metacarpophalangeal (MCP) 2–5 joints, wrist joints 
and metatarsophalangeal (MTP) 1–5 joints. In the EAC 
the most painful side was scanned, or in case of equally 
severe symptoms at both sides the dominant side was 
scanned. In asymptomatic volunteers the dominant side 
was scanned. All persons were asked to stop non-steroidal 
anti-inflammatory drugs at least 24 hours prior to the 
MRI scan. The MRI scans were made prior to the start 
of disease-modifying antirheumatic drugs   (DMARDs) 
(including corticosteroids). An ONI MSK Extreme 1.5T 
extremity MRI scanner (GE, milwaukee, Wisconsin, 
USA) was used. The scan protocol is described in more 
detail in the online supplementary methods. Briefly, 
T1-weighted sequences were acquired. After intravenous 
contrast administration (gadoteric acid, Guerbet, Paris, 
0.1 mmol/kg) T1-weighted sequences with fat saturation 
(T1Gd) were performed. The foot was scanned with 
T2-weighted fat-saturated (T2) and T1 sequences in the 
first 106 patients with RA and with T1Gd in the last 82 
patients with RA. Scoring of synovitis and bone marrow 
oedema (BME) was done according to the RA MRI score 
(RAMRIS) method in the MCP, wrist and MTP joints.14 
Tenosynovitis was scored according to Haavardsholm et 
al15 in the MCP joints and wrist. The total MRI inflamma-
tion score was calculated by summing the synovitis, BME 
and tenosynovitis scores, and ranged between 0 and 189. 
MRI scoring was done independently by trained readers; 
patients with RA were scored by two readers (WPN and 
ECN), and the asymptomatic volunteers were scored 
by another two readers (HWvS and LM). Readers were 
blinded for any clinical data. Furthermore, to exclude 
observer bias introduced by knowledge that persons had 
no symptoms, the MRI images of asymptomatic volun-
teers were mixed with the MRI images of patients with 
RA and patients with arthralgia without clinical synovitis 
(n=99). The within-reader intraclass correlation coeffi-
cients (ICC) of the readers were all greater than 0.93, 
and the between-reader ICCs of the four readers were all 
above 0.91. The mean scores of the two readers were used 
for the analyses.
Analyses
Alcohol consumption was categorised into four groups: 
non-drinkers, participants who consume 1–7 drinks/
week, 8–14 drinks/week and >14 drinks/week, and this 
corresponded to no, one, two and more drinks daily as 
used in some previous studies.3–6 Groups were compared 
with the Kruskal-Wallis test and the Mann-Whitney U test 
when appropriate. The association of alcohol consump-
tion with MRI-detected inflammation was analysed using 
univariable and multivariable linear regressions adjusted 
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Table 1 Baseline characteristics of patients with RA and asymptomatic volunteers in which hand and foot MRIs were 
performed and patients with RA in which CRP was analysed






Patients with RA with CRP 
measurement
n=1070
Age in years, mean (SD) 56 (14) 50 (16) 56 (15)
Female, n (%) 121 (64.4) 135 (70.3) 717 (67.0)
Symptom duration in weeks, median (IQR) 15.4 (7.9–29.6) NA 18.4 (9.1–35.6)
CRP in mg/L, median (IQR) 10.0 (3.8–23.5) NA 14.0 (6.0–33.0)
SJC, median (IQR) 6 (3–10) NA 8 (4–13)
ACPA positivity, n (%) 102 (54.3) NA 550 (52.6)
RF positivity, n (%) 116 (61.7) NA 604 (56.9)
Current smokers, n (%) 50 (28.4) 17 (8.8) 271 (25.7)
Patients consuming alcohol, n (%) 121 (64.4) 135 (69.9) 621 (58.0)
Units/week, median (IQR) 6.0 (3.0–10.5) 7.0 (4.0–14.0) 6.0 (2.0–10.5)
Of patients with RA with an MRI, smoking status and SJC were missing in 12 and 18 patients, respectively. In patients with RA with a CRP 
measurement, smoking status, SJC, RF and ACPA status were missing in, respectively, 17, 38, 9 and 24 patients with RA.
ACPA, anticitrullinated protein antibody; CRP, C reactive protein; NA, not assessed; RA, rheumatoid arthritis; RF, rheumatoid factor; SJC, 
swollen joint count. 
for age, gender, smoking status and anticitrullinated 
protein antibody (ACPA). ACPA was not assessed in 
asymptomatic volunteers, and the multivariable linear 
regression in the asymptomatic volunteers was adjusted 
for age, gender and smoking status. In the linear regres-
sion analyses, MRI inflammation scores were log10-trans-
formed (log10(score +1)) to approximate a normal distri-
bution. To analyse whether a J shape existed in the asso-
ciation between alcohol consumption and CRP levels, a 
linear regression with a piecewise linear spline on one 
alcohol consumption per week was used as this fitted the 
data best. SPSS V.23.0.0 was used for analysis.
Results
Patients
Baseline characteristics are presented in table 1. Sixty-
four per cent (n=121) of patients with RA who underwent 
MRI (see online supplementary figure 1 for a flow chart) 
consumed alcohol at baseline, with a median consump-
tion of 6 drinks/week (IQR 3–11). Of the asympto-
matic volunteers, 70% (n=135) consumed alcohol, with 
a median consumption of 7 drinks/week (IQR 4–14). 
Patients with RA consumed on average one alcohol 
consumption less than the asymptomatic volunteers; this 
difference did not reach statistical significance (P=0.14).
Association of MRI-detected inflammation with alcohol 
consumption in patients with RA
The extent of MRI-detected inflammation was first 
compared in four categories of alcohol consumption. The 
median MRI-detected inflammation in patients with RA 
did not significantly differ between the four categories: 
patients with RA who did not drink alcohol had a median 
MRI inflammation score of 14.8 (IQR=7.0–26.5), patients 
with RA consuming 1–7 drinks/week had a median of 
16.5 (IQR=7.0–27.5), patients with RA consuming 8–14 
drinks/week had a median of 16.8 (IQR=8.5–26.5), and 
patients with RA consuming >14 drinks/week had a 
median of 15.0 (IQR=12.0–40.5) (P=0.53) (figure 1A). 
When analysing BME, synovitis and tenosynovitis sepa-
rately, similar results were seen (see figure 2).
The association between alcohol and MRI-detected 
inflammation was also evaluated, with the number of 
alcohol consumptions on a continuous scale also showing 
no association (β=1.011, 95% CI 0.992 to 1.030, P=0.36). 
To exclude the possibility of non-significance due to the 
presence of confounders, the analysis was subsequently 
adjusted for age, gender, smoking and ACPA. Also, this 
showed no association between alcohol and inflamma-
tion in hand and foot joints (β=0.994, 95% CI 0.975 to 
1.013, P=0.53).
Association of MRI-detected inflammation with alcohol 
consumption in asymptomatic volunteers
In asymptomatic volunteers, the extent of MRI-de-
tected inflammation was also compared in four catego-
ries of alcohol consumption. The median MRI-detected 
inflammation did not significantly differ between the 
four categories: asymptomatic volunteers who did not 
drink alcohol had a median MRI inflammation score of 
1.5 (IQR=0.5–4.0), 1–7 drinks/week 1.5 (IQR=0.5–4.0), 
8–14 drinks/week 2.5 (IQR=1.0–4.0) and >14 drinks/
week 3.5 (IQR=1.0–5.0) (P=0.33) (figure 1B). Analysing 
BME, synovitis and tenosynovitis separately revealed 
similar results (see figure 3).
Assessing alcohol consumption on a continuous scale, 
an association was observed in univariable analysis 
(β=1.018, 95% CI 1.002 to 1.034, P=0.025). However, after 
adjusting for age, the association disappeared (β=1.003, 
95% CI 0.99 to 1.016, P=0.62), and also after adjusting 
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Figure 1 The association between alcohol consumption 
and the severity of MRI-detected inflammation in hand and 
foot joints of (A) patients with RA and (B) asymptomatic 
volunteers. The lines presented in the figure represent 
median values. MRI-detected inflammation does not differ 
significantly between the four groups in patients with RA and 
asymptomatic volunteers (P=0.53 and P=0.33, respectively). 
RA, rheumatoid arthritis.
Figure 2 The association between alcohol consumption 
and the severity of (A) synovitis, (B) BME and 
(C) tenosynovitis in patients with RA. The lines presented 
in the figure represent median values. Synovitis, BME and 
tenosynovitis scores did not differ significantly between the 
four groups in patients with RA (P=0.60, P=0.47 and P=0.85, 
respectively). BME, bone marrow oedema; RA, rheumatoid 
arthritis. 
for age, gender and smoking status no association was 
observed (β=1.002, 95% CI 0.99 to 1.015, P=0.76).
Association of alcohol consumption and CRP in patients with 
RA
Because of the negative findings done thus far, we 
searched for a positive control and we wished to verify 
if the previously observed association between alcohol 
consumption and CRP was present in our cohort of 
patients with RA. In a total of 1070 patients with RA, 
58% consumed alcohol, with a median consumption 
of 6 drinks/week (IQR=2–11). The median CRP level 
in non-drinkers was 16 mg/L (IQR=6–37 mg/L), 
in patients who consume 1–7 drinks/week the 
median was 11 mg/L (IQR=5–29 mg/L), in patients 
who consume 8–14 drinks/week the median was 
16 mg/L (IQR=6–31 mg/L), and in patients who 
consume >14 drinks/week the median was 19 mg/L 
(IQR=6–41 mg/L). The median CRP levels between 
these four groups differed significantly (P=0.043). 
Evaluation by eye suggested the presence of a J-shaped 
effect, with the lowest CRP in the group that consumes 
1–7 drinks/week. Indeed comparing this group with the 
non-drinkers revealed a significant difference (P=0.011, 
figure 4). To further confirm this J-shaped effect, a 
piecewise linear spline regression was used. The regres-
sion was divided into two regression coefficients of the 
J curve (eg, the left decreasing part (compared with 
no drinks/week), and the right increasing part with 
the lowest CRP level on 1 drink/week). One drink/
week was chosen as this corresponded to the lowest 
CRP levels. Indeed this piecewise regression showed 
that CRP level decreased significantly with increasing 
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Figure 5 The association between alcohol consumption 
and SJC in patients with rheumatoid arthritis. The lines 
presented in the figure represent median values. A 66 SJC 
was evaluated. The SJC does not differ significantly between 
the groups (P=0.23). SJC, swollen joint count.
Figure 3 The association between alcohol consumption 
and the severity of (A) synovitis, (B) BME and 
(C) tenosynovitis in asymptomatic volunteers. The lines 
presented in the figure represent median values. Synovitis, 
BME and tenosynovitis scores did not differ significantly 
between the four groups in asymptomatic volunteers 
(P=0.81, P=0.44 and P=0.15, respectively). BME, bone 
marrow oedema.
Figure 4 The association between alcohol consumption 
and CRP levels in patients with rheumatoid arthritis. The lines 
presented in the figure represent median values. CRP differs 
significantly between the groups (P=0.043). CRP, C reactive 
protein.
alcohol consumption up until a maximum of 1 drink/
week (β=0.80, 95% CI 0.68 to 0.93, P=0.003). In patients 
consuming >1 drink/week, CRP levels increased 
significantly with increasing alcohol consumption 
(β=1.015, 95% CI 1.004 to 1.025, P=0.006). Hereby, the 
visually observed J-shaped association was statistically 
confirmed. In a multivariable analysis adjusting for age, 
gender, smoking and ACPA status, the downward part 
of the J curve was still present (β=0.85, 95% CI 0.73 
to 0.99, P=0.039), but the upward part of the J curve 
lost its statistical significance (β=1.007, 95% CI 1.00 to 
1.017, P=0.214). A beta of 1.007 indicates that for every 
drink/week increase in alcohol consumption, there is 
an 1.007-fold increase in CRP level; thus, in patients 
consuming >1 drink/week higher alcohol consumption 
was associated with a higher CRP level.
Finally the number of swollen joints in these patients 
at disease presentation was studied in relation to alcohol 
consumption. No association was observed (figure 5).
dIsCussIOn
Moderate alcohol consumption has been associated 
with less severe systemic inflammation (generally meas-
ured using CRP levels) in the general population.1 2 Also 
within patients with RA, it has been shown repeatedly 
that moderate alcohol consumption lowers the risk of 
developing RA and is associated with less severe systemic 
inflammation.3 4 Because of these findings, we hypothe-
sised that moderate alcohol consumption might also be 
associated with less severe inflammation in joints, which 
can be sensitively detected with MRI. The current data 
revealed no association between alcohol consumption 
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and the severity of local inflammation in hand and foot 
joints on MRI. Similar to a previous study, we also found 
no association with the number of swollen joints. Thus, 
although moderate alcohol consumption is associated 
with lower levels of systemic inflammation and a lower 
risk to develop RA, based on the present findings it is not 
associated with less severe inflammation in joints.
The pathophysiological mechanism underlying 
the association between alcohol consumption and 
inflammation is unknown. Different studies explored 
the immunoregulatory effects of alcohol and various 
results have been observed. High alcohol consump-
tion has been reported to be associated with depleted 
cell-mediated and humoral immune responses,16 
whereas other data suggest that low alcohol consump-
tion has a stimulatory effect on the cellular immune 
response.17 Furthermore, higher alcohol consumption 
was observed to associate with lower levels of tumour 
necrosis factor receptor II and IL-6,6 whereas moderate 
alcohol consumption (7–14 units/week) associated with 
increased levels of IL-2, IL-4 and IL-10, cytokines that 
are known for anti-inflammatory activities.17 In addi-
tion, a U-shaped association between alcohol consump-
tion and IL-6 levels is reported.6 These findings are in 
line with the observed association between alcohol and 
the systemic inflammatory marker CRP.
Distinguishing high alcohol consumption from 
moderate alcohol consumption has several pitfalls. In 
this study, assessment of alcohol consumption is based 
on questionnaires and could therefore deviate from 
the true alcohol consumption. Information on alcohol 
usage was collected by the number of drinks, assuming 
common portion sizes: beer (1 glass or bottle), wine 
(4-ounce glass) and liquor (1 drink or shot). This is 
similar as done by others, and the alcohol content is 
estimated to be 10–15 g per drink.18 In addition we did 
not collect information on the type of alcohol, which is 
a limitation. Previous large studies have revealed that 
most persons drink more than one type of alcohol, 
which makes stratification difficult.1 Furthermore 
there is controversy on the importance of the type 
of beverage. Although it has been suggested that the 
protective effect of alcohol on systemic markers of 
inflammation is confined to red wine, several studies 
investigating this issue did not find different effects 
for different types of alcohol.19–22 Although we cannot 
make conclusions for different beverages, the fact that 
the association of alcohol consumption and CRP levels 
in this study resembles the associations found in the 
literature1 supports the validity of the data on alcohol 
consumption.
Alcohol consumption is part of a lifestyle and might 
therefore be a proxy for other factors associated with life-
style. So the association of alcohol on joint inflammation 
might have been influenced by other factors. Multivar-
iate analyses were performed to adjust for some of these 
factors (among others, age and smoking), but this did 
not majorly influence the study results.
The lack of association between alcohol consumption 
and the extent of local joint inflammation on MRI found 
in this study might have been caused by an inadequate 
power to detect an effect of alcohol on joint inflamma-
tion on MRI, especially as the previously observed effect 
of alcohol on systemic inflammatory markers, such as 
CRP levels, was generally observed in very large studies.1 
MRI is more time-consuming and more expensive to 
perform than, for example, CRP level measurements, 
making an MRI study within thousands of patients with 
RA infeasible. In our view there was not even a trend 
towards an association between alcohol and local inflam-
mation; furthermore, in the total group of 1070 patients, 
alcohol did also not associate with the number of clini-
cally swollen joints. Altogether this makes it unlikely that 
the present finding is falsely negative.
The present study in early RA had a cross-sectional study 
design. This allowed us to perform measurements before 
disease-modifying treatment was initiated. A longitudinal 
study is needed to evaluate the association between alcohol 
and long-term outcome of RA, but current treatments and 
treat-to-target strategies may mask an effect of alcohol (if it 
is present) on the course of RA.
According to the European Society of Musculoskel-
etal Radiology recommendations, BME was evaluated on 
T1Gd. The RAMRIS method suggests to use T2, but T2 
was omitted from our scan protocol since previous studies 
have shown that these sequences perform equally well to 
depict BME,23 24 and a T1Gd has already been used to 
assess synovitis and tenosynovitis. This allowed a shorter 
imaging time for the participants.
Healthy, asymptomatic volunteers can also have some 
subclinical inflammation in hand and foot joints, espe-
cially at older age. The nature of this inflammation is 
incompletely clear. Immunosenescence or degenera-
tion may play a role. Although the origin is incompletely 
known, we speculated that a potential effect of alcohol 
on joint inflammation might also be present in persons 
without RA. But similar to patients with RA, alcohol did 
not influence the severity of subclinical inflammation in 
hand and foot joints of asymptomatic volunteers.
In conclusion, moderate alcohol consumption has 
been shown to have a beneficial effect on the risk of RA 
development and inflammatory markers, and the present 
study confirmed a J-shaped association between alcohol 
and CRP, and we observed no association between alcohol 
and the extent of local inflammation in joints. Therefore 
the present data suggest that the pathophysiological 
mechanism underlying the effect of alcohol consists of a 
systemic effect that might not involve the joints.
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